Grape King Bio (1707.TW) Earnings Analysis

Grape King Bio (1707.TW) has no confirmed upcoming earnings date. Last quarter (2026-05-11) it missed with EPS 1.18 TWD vs 1.36 TWD est (-13.2%). It has beaten estimates in 2/6 recent quarters (33%). Trailing P/E 11.35.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 1707.TW next report earnings?

No confirmed upcoming earnings date is currently scheduled for 1707.TW. This page updates as the calendar is published.

1707.TW earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-111.18 TWD1.36 TWD-13.2%Miss
2026-03-042.84 TWD2.84 TWD0%Beat
2025-05-121.4 TWD1.9 TWD-26.3%Miss
2025-02-242.99 TWD3.6 TWD-16.9%Miss
2024-11-112.8 TWD2.43 TWD+15.2%Beat
2024-08-122.21 TWD2.42 TWD-8.7%Miss

Beat rate: 2/6 (33%) over reported quarters with consensus data.

1707.TW valuation and analyst view

Trailing P/E11.35
Trailing EPS4.883 TWD
Price / book2.21
Dividend yield6.61%
Market cap13.42B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Grape King Bio (1707.TW)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 1707.TW. This page updates as the calendar is published.

Did 1707.TW beat earnings last quarter?

In its 2026-05-11 report, 1707.TW posted EPS of 1.18 TWD versus a 1.36 TWD estimate — a miss of 13.2%.

What is 1707.TW's earnings track record?

Over the last 6 reported quarters with consensus data, 1707.TW beat estimates 2 times (33%).

What is 1707.TW's current P/E ratio and EPS?

1707.TW trades at a trailing P/E of 11.35 on trailing EPS of 4.882978109887213 TWD.

What do analysts rate 1707.TW?

1707.TW has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.